All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 8 out of 8 Insights
-
Active Filters
-
How Do We Match the Right Drug to the Right Patient?
HealthSpark, Episode 20: Tanya M. Laidlaw, MD, Professor of Medicine at Harvard Medical School and allergist-immunologist at Brigham and Women’s Hospital, shows how treating severe asthma with advanced biologics can still feel like trial-and-error, and why linking patient experience, biomarkers, and research is critical to getting treatment right the first time.
-
New Hope for Patients with Pancreatic Cancer
In this episode of Science Snapshot, learn how a new once-daily pill called daraxonrasib is nearly doubling median survival for previously treated metastatic pancreatic cancer patients.
-
How Do We Turn Global Unmet Need into Sustainable Patient Access?
HealthSpark, Episode 14: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, explores how strategic decisions in health technology and delivery can transform markets and patient lives by expanding sustainable access to high-quality care around the world.
-
Investigational GLP-1-Based Medicine Uses Triple Targeting to Accelerate Weight Loss
In this episode of Science Snapshot, learn how retatrutide, an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, showed 28.3% average weight loss at 80 weeks, surpassing currently approved injectables in separate trials.
-
New Evidence For How Lithium Affects Alzheimer’s Pathology in the Brain
In this episode of Science Snapshot, learn how amyloid plaques may trap lithium, lowering it in parts of the brain tied to memory, and how a low dose of lithium orotate reduced Alzheimer pathology and improved memory in mouse models.
-
What’s Next for the Biopharmaceutical Industry and Why Ongoing Learning is Key
The COVID-19 pandemic has led to three key trends in the biopharmaceutical industry: new therapeutic modalities, increased data usage, and stronger collaboration between industry and academia.
-
RWD: Responding to Regulatory and Drug Development Challenges
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
-
Leveraging Genetic Insights Throughout the Drug Discovery Pipeline
Robert M. Plenge, MD, PhD, senior vice president in research and early development and head of the immunology, cardiovascular, fibrosis, and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
